Please ensure Javascript is enabled for purposes of website accessibility
Главная > Рекомендуемая продукция > Стабильная клеточная линия
CHO Human CLDN18.2 Stable Cell Line
CHO Human CLDN18.2 Stable Cell Line
Цена(USD):
Спецификация:
  • 1 ml
Количество:
Свяжитесь с нами
  • Обзор

  • Изображения

  • Ссылки

  • Даташит

Обзор
Каталожный номерHX126828
Описание
CHO Human CLDN18.2 Stable Cell Line (HX126828) is a stable cell line expressing CLDN18.2. Engineered for consistent, high-level target expression in research applications.
Highlights
  • ●Stable Expression — Engineered for consistent, high-level target expression.
Номер доступаP56856
ПримененияFCM
Хозяинский видCHO
ВидыHuman
Цель CLDN18.2
Метод обнаружения Colorimetric
Тип образца Plasma, Serum
Тип анализа Quantitative
Диапазон 1.56 - 100 ng/mL
Чувствительность 0.25 ng/mL
Восстановление 80-120%
Свойства Growth Properties: Adherent; Selection Marker: Puromycin (1 μg/mL)
Доставка 2-8 ℃
Устойчивость и хранение Frozen in liquid nitrogen.
Характеристики 1 vial contains at least 2×10^6 cells in 1 mL Freeze Medium
Фон

Claudin-18 (CLDN18.2) is a ~27 kDa protein. Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling. Required for lung alveolarization and maintenance of the paracellular alveolar epithelial barrier. Acts to maintain epithelial progenitor cell proliferation and organ size, via regulation of YAP1 localization away from the nucleus and thereby restriction of YAP1 target gene transcription. Acts as a negative regulator of RANKL-induced osteoclast differentiation, potentially via relocation of TJP2/ZO-2 away from the nucleus, subsequently involved in bone resorption in response to calcium deficiency. Mediates the osteoprotective effects of estrogen, potentially via acting downstream of estrogen signaling independently of RANKL signaling pathways. CLDN18.2 is the therapeutic target of zolbetuximab (Vyloy).

Примечание For research use only. This stable cell line expresses GFP as a reporter marker. GFP is expressed independently of the target protein and is not fused to the target protein.
Изображения
  • CHO Human CLDN18.2 Stable Cell Line

    Flow cytometry

    Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CLDN18.2 monoclonal antibody at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

Ссылки
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Рекомендация

Свяжитесь с нами для индивидуальных предложений, оптовых запросов и других вопросов.

Почта: [email protected]

Список дистрибьюторов